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Risk factors for surgical site infection in breast surgery 
 
 
Aims and objectives: The aim of this paper is to study risks for surgical site infection in 
breast surgery. The objectives were to measure the association of postoperative infection 
with patient- and procedure-related factors. 
Background: The infection rate in breast surgery is expected to be low but it varies a lot. 
The variation is recommended to be assessed by measuring procedure-related factors.  
Design: A retrospective chart review of 982 breast surgery patients was completed.   
Method: The data on patient demographics, procedure types, patient and surgery-related 
factors were collected. A multivariate logistic regression model for all breast operations 
(N=982), lumpectomies (n=700) and mastectomies (n=282) was performed.  
Results: The infection-rate was 6.7%. In a multivariate logistic regression model for all 
operations, a contaminated or dirty wound; high American Society of Anesthesiologists  
score; high body mass index; use of surgical drains; and re-operation predicted increased 
infection risk. In lumpectomies high body mass index and use of surgical drains predicted 
increased risk. In mastectomies, the significant predictor was re-operation. 
 Conclusions: The surgical site infection rate was high. In addition to the two classical 
risks (high wound-class and anaesthesia risk) high body mass index; re-operation; and 
use of surgical drain increased the infection risk among all patients.  
Relevance to clinical practice: In breast surgery careful assessment, documentation and 
adherence to aseptic practices are important with all patients. Patients with heavy weight 
need special attention. The need for antimicrobial prophylaxis in re-operations, and the 
need of surgical drains in lumpectomies are important to consider carefully. 
 
Keywords: Breast surgery, patient-related risk factors, procedure-related risk factors, 
surgical site infection, mastectomy, lumpectomy 
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Introduction 
 
This paper describes some results of a quality improvement program aiming to improve 
aseptic practices (AP) in surgeries of one Finnish university hospital (Aholaakko 2011). 
During the program the Association of Operating Room Nurses (AORN 1999) 
recommendations were culturally validated and documented with evidence base. The AP 
was defined as means of minimizing wound contamination during invasive procedures. 
The AP was classified by six subcategories: (1) preparation of the personnel and (2) 
preparation of the patient for the surgery; (3) central services; (4) environmental services; 
(5) aseptic behaviour and (6) aseptic technique during creation, maintenance and 
discharge of the sterile field. The breast surgery patients were defined as a target patient 
group and the postoperative surgical site infection (SSI) rate was used as an outcome 
indicator of the program. There was no statistically significant improvement in it after the 
program.  This paper describes the patient-related and procedure-related risk factors for 
the SSI after breast surgery.  
 
Background  
Breast surgery is classified as “clean” surgery in which the expectation of SSI is low 
(Centers for Disease Control and Prevention 2004, Alexander et al. 2011, de Blacam et al. 
2012). The SSI rates after mastectomies varied from 1.7% to 11% so that after a primary 
mastectomy the rate was from 2.6% to 6.4%, and after reoperation from 7.6% to 11% 
(Chen et al. 1991, Jarvis et al. 1998, Gaynes et al. 2001, Moro et al. 2005, Monge Jodrá et 
al. 2006, Rioux et al. 2007). Inadequate wound care was reported among breast cancer 
patients with a SSI rate of 13.7% to 33.1% (Vilar-Compte et al. 2006). The rate was 18.9% 
after a quality improvement program (Vilar-Compte et al. 2009). In the research hospital of 
Risk factors for SSI in breast surgery 
 
3
the current study the adherence to the AP-recommendations during breast surgery was 
varying a lot and it was found as stressful (Aholaakko 2011).  
 
Complications like SSI cause readmissions and subsequent surgeries with increased 
hospital costs and considerable patient distress (Olsen et al. 2008, de Blacam et al. 2012). 
Procedure-related factors are recommended to be measured if large variation exists in SSI 
rate between hospitals (Geubbels et al. 2006).  
 
Risk factors in breast surgery and universal patient-related SSI risk factors (high wound 
class, high American Society of Anesthesiologists  ASA-score, and long duration of 
operation) were found as controversial (NNIS 2002, Miner et al. 2004, McKibben et al. 
2005, Prospero et al. 2006, Bunn et al. 2006, Friedman et al. 2007, Rioux et al. 2007).  
The SSI rate was reported as lower in non-cancer than in breast cancer surgery (Olsen et 
al. 2008, Vilar-Compte et al. 2009). This may be due to the high-risks of more extensive 
procedures with drain-usage (Throckmorton et al. 2009). Also the preoperative chemo and 
radiation therapy; hematoma; the body mass index (BMI) 30 kg/m2 or over; age of 58 or 
over; and long duration of surgery (160 minutes or more) were defined as SSI-risks (Olsen 
et al. 2008, Vilar-Compte et al. 2009).  
 
According to de Blacam et al. (2012) the mastectomy patients had more SSIs (3.2%) than 
lumpectomy patients (1.4%). They tended to have more co-morbidities, like DM, and they 
were older than lumpectomy patients. The independent SSI risks for both mastectomy and 
lumpectomy patients were BMI of 25 kg/m2 or higher, and being a smoker. The 
independent SSI risk for lumpectomy patients was having a prior operation within 30 days. 
Among mastectomy patients, the mean age and the mean duration of the hospital stay 
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was higher for those with infection than for those without infection (Chen et al. 1991, Vilar-
Compte et al. 2006, Olsen et al. 2008.) 
 
Prospective randomized studies have shown a clear benefit after the use of antimicrobial 
prophylaxis (AMP) in elective operations such as breast procedures (Alexander et al. 
2011). In small scale or clinical studies the benefit was not this clear. In breast surgery 
without AMP, a single antimicrobial dose administered approximately 30 min before 
surgery; the SSI risk was reported as 12% (Platt et al. 1990). AMP of 24-hours duration 
compared with post-mastectomy antimicrobials reduced SSI rate from 7.6% to 3.4% (Chen 
et al. 1991). AMP was recommended in mastectomy of cancer patients, but a reduction in 
SSI rate was not always observed (Bunn et al. 2006). No statistically significant SSI 
reduction was found among patients who received both pre- and postoperative AMP 
compared to those with preoperative AMP only (Throckmorton et al. 2009). According to 
Wagman et al. (1990) the AMP administration 30 min before skin incision did not reduce 
SSI rate, but prolonged SSI onset.  
 
Perioperative interventions breaking the skin integrity were potential SSI risks. Surgical 
removal of hair was reported to be associated with SSI when the hair was removed by a 
razor (Alexander et al. 2011). Using the clippers resulted in fewer SSIs than using a razor 
(Tanner et al. 2006, Kjønniksen et al. 2002). In mastectomies, all postoperative SSIs were 
reported after axillary dissection, half of these in the open biopsy site (Wagman et al. 
1990). Complications were not reported after wire-guided biopsies (Chadwick & 
Shorthouse 1997). Preoperative marking of tumours with wire or ink was not associated 
with SSI, but core needle biopsy with older age predicted a SSI risk of 15% (Witt et al. 
2003).  
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The postoperative use of closed suction drains might be useful for the removal of fluid from 
large potential dead spaces, but did not prevent infections (Alexander et al. 2011). In 
general surgery (including mastectomies) the use of surgical drains for longer than five 
postoperative days increased SSI risk (Moro et al. 2005). The use of surgical drains 
increased pain and prolongs hospital stay after mastectomy and lumpectomy, but no 
difference in SSI rate was reported (Jain et al. 2004). After lumpectomy or mastectomy, 
SSI did not occur with the use of surgical drains unless the fluid volume was under 50 ml 
(Oertli et al. 1994). The pre- and postoperative administration of AMP did not reduce the 
SSI rate of patients with nine days median length of time to drain removal when compared 
with those who received preoperative AMP only (Throckmorton et al. 2009).          
 
In the present study, we focused on the risks for SSI in breast surgery. Our objectives 
were to measure if the SSI after lumpectomy or mastectomy was associated with: (1) 
patient-related factors and 2) procedure-related factors. 
 
Methods 
Data collection 
Data regarding breast surgery (N=1042) was collected from January 1999 to November 
2000 and from January 2002 to March 2003 in two hospitals of Helsinki University Central 
Hospitals (HUCH). The documents of one patient were unavailable, and those from 
another patient were incomplete. Patient charts were delivered according to computer-
based lists. All surgery related documents were reviewed. Data was also searched from 
computer-based operation statistics. The type of surgery was identified by using the name, 
national identity code, procedure codes and diagnosis of the patient. The registered SSIs 
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that occurred within 30 days after the operation were diagnosed by a physician according 
to the classical symptoms of infection: purulent drainage; spontaneously dehisced incision; 
or wound opened by a surgeon, and classified as “superficial”, “deep incisional”, or “organ 
space” (Emori et al. 1991, Crowe & Cooke 1998, Wilson et al. 2004). The Infection Control 
Nurses of study hospitals validated the registered SSIs from hospital infection registers 
and confirmed the unregistered SSIs from patient charts and data collection forms together 
with one of the researchers (T-KA) at the end of data collection. 
 
The following data of patient-related risk factors were collected: age ≥65 years; ASA score 
of 3–5; presence of diabetes mellitus (DM); presence of re-operation; and a BMI of ≥25 
kg/m2, calculated as height in kilograms divided by height in meters squared (de Blacam 
et al. 2012). Preoperative hospital stay of 48 hours or more; administration of AMP defined 
as a single antimicrobial dose administered 30–60 min before surgery (Platt et al. 1990); 
surgical removal of hair; skin condition; invasive tumour marking; and use of surgical 
drains were used as procedure-related risk factors. The risk due to the long operating time 
was identified in the fourth time quartile of observed operations instead of the National 
Nosocomial Infection Surveillance (NNIS) cut off point of two or three hours (Jarvis et al. 
1998).  
 
Statistical analysis 
Descriptive characteristics of the patients with breast cancer and operations were 
measured. The patient- and procedure-related characteristics were used as independent 
variables when calculating the initial risk factors for SSI. All breast operated; lumpectomy; 
and mastectomy patients with SSIs were compared with those without SSIs. Univariate 
odds ratios (ORs) were calculated first (Table 1). The dependent variable (SSI) was 
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dichotomized. It was coded simply 0=no SSI, 1=defined SSI. This caused loss of 
information, but made it possible to use logistic regression as an analysis method. Using 
logistic regression instead of general logistic modelling gave a more reliable prediction 
because the dependent variable did not distribute according to a normal curve. Variables 
of patient- and procedure-related factors were used as covariates. Dichotomous variables 
were formed out of some independent variables as the candidate risk factors for SSI. For 
the multivariate models they were selected on the basis of previous research and 
significance of univariate analysis. The methodological grounds for this were to improve 
the reliability of clinical data (Munro 1997, 287-309, Gomm 2004, 139-149).  
 
Separate multivariate logistic regression models for all observed operations, and for 
lumpectomies and mastectomies, were carried out. The intervals (CI) were reported to 
demonstrate more clearly the odds ratio and the statistical significance of the results. For 
the logistic regression, the normality of residuals was tested by probability plots. The 
homoscedasticy of residuals was explored by plotting residuals. Residuals appeared to be 
randomly scattered. The -2 Log Likelihood (-2LL) was used as a measure of how well the 
estimated model fits the data. A good model is one that results in a high likelihood of the 
observed results. (Munro 1997, 287-309.) Statistical analysis was performed with the 
SPSS software package version 16.0 (Chicago, IL). 
 
 Results 
The study consisted of 982 breast operations. The age range of breast surgery patients 
was 16–97 years, with a mean of 55 (±12.57) years. Ninety-eight percent of patients were 
female. Six per cent of patients had signs of pre-operative infection. The cancer was 
diagnosed preoperatively in 61% of subjects. DM rate was four per cent. BMI of the 
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patients varied from 11 kg/m2 to 55 kg/m2.  
 
Eighty-four per cent of patients arrived at the hospital on the day of surgery and one per 
cent earlier. Fifteen percent visited the hospital day before surgery. Surgical hair removal 
was documented to perform in 41% of the operations. Preoperatively the patients’ skin in 
surgical site was assessed as intact for 80% of the operations. Signs of preoperative 
infection were noted in six per cent. Preoperative invasive procedures were performed in 
55% of operations. Sentinel puncture was done in 10% of operations, wire marking in 
35%, and other punctures (e.g., ink application) in three per cent of operations. Rest of the 
patients had anaesthesia related punctures.   
 
Antimicrobials were administered in seven per cent of the operations (n=69). In fifteen 
operations AMP was administered 30 minutes prior incision and in eight operations closer 
than that. In six operations it was given during incision and in twenty five operations after 
it. In fourteen operations the time of administration was not documented. AMP was 
administrated for a reason other than surgery to one patient. The surgeon had influenza.  
 
Of 982 breast operations 700 (72%) were lumpectomies and 282 (28%) mastectomies with 
or without axillary dissection. Fifty-seven per cent of all patients had an axillary evacuation. 
The occurrence of re-operations was 28% and that of several re-operations one per cent. 
Mean operation time was 64.83 (±40.38) min. Operating time comprised a first quartile of 
3–32 min, second of 33–58 min, third of 59–86 min and the fourth quartile of 87–502 min. 
The 75th percentile cut-off time was 87 minutes.  
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Sixty-six SSIs were identified. The SSI rate among all breast operations was 6.7%; after 
lumpectomy 4.7%; and after mastectomy 8.9%. The most common SSIs were deep 
incisional (n=37, 56%), followed by superficial (n=22, 33%) and organ-space (n=7, 11%). 
In 24% of 769 documents it was possible to define variation of postoperative visits to 
hospital. Of the patients 111 had more than one postoperative visit. Eighty seven patients 
visited in surgical ward and 19 (1.9%) in Emergency Room due to SSI. One patient had a 
health centre visit. Eleven patients (1.1%) had readmission due to SSI and four (0.4%) due 
to systemic complications.  
 
Patient- and procedure-related initial risk factors for SSI were identified (Table 1). The risk 
was increased for patients with ASA scores of 3–5 compared with patients with ASA score 
1 or 2. If the wound class was “contaminated” or “dirty”, the risk for SSI was higher than for 
“clean” or “clean contaminated” wounds. Three patients were classified as having a 
contaminated wound and six as having a dirty wound. The BMI of ≥25 kg/m2 increased the 
SSI risk. Re-operated patients had higher SSI risk compared with patients who had one 
operation.  
  
The multivariate logistic regression models were calculated for all operations, 
lumpectomies and mastectomies to predict SSI risks (Table 2). In all operations, four 
patient-related risks were found to be statistically significant. Patients with an ASA score 
3–5 had a higher SSI risk compared with healthy patients. Contaminated or dirty wound 
class predicted an increased SSI risk. Patients with a BMI ≥25 kg/m2 had a higher risk for 
SSI compared with patients having normal or low weight. The risk of re-operated patients 
was higher when compared with patients who had undergone one operation. Re-operation 
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predicted increased patient-related SSI risk both in lumpectomies and mastectomies. A 
high BMI increased SSI risk in lumpectomies.  
 
One procedure-related factor was statistically significant. Use of a surgical drain predicted 
increased risk for SSI in all operations. The risk was statistically significant also in 
lumpectomies, but not in mastectomies (Table 2).   
 
Discussion 
In this study the SSI rate was high when compared with the international 
recommendations (Olsen et al. 2008, Alexander et al. 2011). After lumpectomy the rate 
was 4.7% and 8.9% after mastectomy. This kind of difference was reported earlier 
(Throckmorton et al. 2009) and it was used to justify the procedure-specific follow-up of 
SSI in this study. The SSI rates in the present study were higher than in most surveillance 
studies (Jarvis et al. 1998, Yokoe et al. 1998, NNIS 2002, Monge Jodrá et al. 2006), but 
lower than in the observational studies of Vilar-Compte et al. (2006, 2009). The variations 
in SSI rates may occur due to the differences in data collection. According to Moro et al. 
(2005) the intensity of post-discharge surveillance may in part explain the observed 
difference in SSI rate. 
 
The classical patient-related risks for SSI (Emori et al. 1991) were supported by the results 
of univariate analysis. In multivariate analysis, the presence of high ASA score; 
contaminated or dirty wound; and high BMI were the patient-related risk factors in all 
operations. In lumpectomy (but not in mastectomy), a high BMI was the most predictive 
patient-related risk. This may be due to the procedure; the small number of mastectomies 
in the present study; or the used BMI value which was lower than the one used by Vilar-
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Compte et al. in 2006 and 2009, and Olsen et al. (2008). In future studies, in addition to 
classical SSI risks, it would be important to control the skin condition at the surgical site, as 
well as the performance of the axillary component of the surgery. This might help to 
separate patient- and procedure-related risks, and enhance the prediction of SSI risk 
(Reilly et al. 2006). 
   
The importance of procedure-related factors for SSI has been discussed, but consensus 
concerning the indicators is lacking. In the present study, AMP was administrated to only 
seven per cent of the patients, which may be too low to improve the SSI rates. In the 
literature, the association between AMP and SSI is controversial (Miner et al. 2004, 
Geubbels et al. 2006, Monge Jodrá et al. 2006). Our findings support the recommendation 
to consider preoperative AMP for the breast cancer patients, especially for those having 
re-operations (Bunn et al. 2006). Re-operation increased the SSI risk in all breast surgery. 
It was the only statistically significant patient-related risk factor in mastectomies. The high 
number of readmissions and subsequent surgeries due to SSIs cause increased hospital 
costs and stress for the patients. High infection rate of mastectomy patients is important to 
decrease due to the success of the potential post-mastectomy breast-reconstructions.  
(Olsen et al. 2008, Throckmorton et al. 2009).   
 
Of the procedure-related factors, surgical removal of hair, invasive interventions, and 
breaks in skin integrity did not predict the SSI. In this present study surgery nurses 
documented a high number of problems related to skin integrity, but defined few wounds to 
be contaminated or dirty. This may represent the real preoperative situation or 
underestimation of the contaminated or dirty wounds. In future studies it would be 
beneficial to document the wound class of the operation according to the current situation, 
Risk factors for SSI in breast surgery 
 
12
not the type of surgery. This is important when investigating the association between SSI 
and preoperative interventions with controlled skin integrity. It will be important also when 
measuring the association between SSI, AMP and the number of re-operations more 
carefully than in this study.  
 
The NNIS-derived operation time for mastectomy has increased since the 1990s (NNIS 
2002, Miner et al. 2004). It is criticised as being too long (Friedman et al. 2007). The 
locally calculated procedure specific operating time cut point over 75th percentile is 
advised to used instead (Moro et al. 2005, Prospero et al. 2006, Vilar-Compte et al. 2006). 
In this study the operation time, first measured as a continuous, later as a dichotomous 
variable, was not a statistically significant risk for SSI. The local cut-off time of the 75th 
percentile (87 minutes) instead of the 2–3 hours operation time recommended by the NNIS 
(Jarvis et al. 1998, NNIS 2002, Friedman et al. 2007) was used. Compared to the 
operation times of this study the NNIS time occurred to be too long. So the results of this 
current study should be compared to the results of NNIS with care. 
 
Geubbels et al. (2006) pointed out that procedure-related SSI risk factors should measure 
common practices, be valid for various healthcare settings, and be clearly specified. 
Factors like the use of surgical drains vary according to surgery type. The use of drains is 
associated with pain and increased hospital stay, but not necessarily with increased rate of 
SSI (Jain et al. 2004, Classe et al. 2006). The exposure to open surgical drains for over 
five days increased the risk of SSI (Moro et al. 2005). In the present study, there was an 
association between the use of closed surgical drains and increased SSI rate in all 
operations and lumpectomies, but not in mastectomies. This may be due to the difference 
in size of the study groups. It also may indicate a tangible difference between the groups. 
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In the future it is important to test these findings in more carefully constructed study 
groups. The importance of relevant surgical and aseptic techniques with surgical drains 
during intra- and postoperative care is important to study. Existence of postoperative 
seroma, type of vacuum used, amount of fluid drained, maintenance of a closed system, 
and the time of drain removal might be interesting parameters to investigate.   
 
Study limitations 
In this study the data from patient documents and hospital statistics was used. It was 
collected as a routine part of care and reflected the conditions, treatments, and definitions 
made in clinical settings by many surgical professionals (Gastmeier et al. 1999). This 
possible lack of consistency and under-reporting may cause unreliable judgements 
(Gomm 2004, 139-149). The missing data excluded 22 patients from the SSI risk analysis. 
The aim was to collect simple and objective data, but the comparability of the results of 
present study and those in the literature is limited (Gaynes et al. 2001, NNIS 2002, Bunn 
et al. 2006, Monge Jodrá et al. 2006, Prospero et al. 2006). The broad confidence intervals 
of some variables (Table 1) meant that the study group was not large and homogenous 
enough.  
 
Making the dependent variable (SSI) dichotomous caused loss of information, but made it 
possible to use logistic regression as an analysis method. Using logistic regression instead 
of general logistic modelling gave a more reliable prediction because the dependent 
variable did not distribute according to a normal curve. We formed dichotomous variables 
out of some independent variables. The methodological grounds for this were to improve 
the reliability of clinical data (Munro 1997, 287-309, Gomm 2004, 139-149).  
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Ethical considerations 
The appropriate hospital authorities gave permission to conduct this study in surgeries of 
two HUCH hospitals. After the target patient group was identified, the ethical board of 
HUCH gave their acceptance. Good ethical practice, privacy, and respect of the rights of 
patients and personnel were undertaken during the study. 
 
Conclusions 
The overall SSI rate of observed breast operations was high when compared with 
international findings. The high ASA score, wound contamination, and re-operation 
predicted the SSI of all breast operated patients; and the use of drain and high BMI the 
SSI of lumpectomy patients. Re-operation was the only significant risk factor among all 
three study groups. It is therefore important to consider AMP for all re-operated breast 
surgery patients.  
 
The use of surgical drains was identified as a procedure-related SSI risk in all breast 
operations and lumpectomies, but not in mastectomies. So the use of surgical drains and 
the other indicators used as procedure-related factors to predict SSI among breast 
operated patients requires further investigation.  
 
Relevance to clinical practice 
According to Alexander et al. (2011) the target SSI rate in breast surgery is 0.5%. So the 
proper implementation of infection prevention guidelines to control the unacceptably high 
SSI rates is necessary. The findings of this study indicated the importance of more precise 
definition of the patient- and procedure-related risk factors for SSI in breast surgery. This 
study revealed also the need for more careful perioperative documentation of clinical 
aseptic practice and patient status information. In breast surgery careful patient 
assessment; detailed documentation; and adherence to aseptic practices are important 
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with all patients. Patients with heavy body weight need special attention. The need for 
antimicrobial prophylaxis in re-operations, and the management of surgical drains in 
lumpectomies are important to consider carefully. 
  
 
 
References 
Aholaakko T.-K. (2011) Reducing surgical nurses’ aseptic practice related stress. Journal of Clinical Nursing 
20(23-24), 3339–3350.  
 
Alexander J.W., Solomkin J.S. & Edwards M.J. (2011) Updated Recommendations for Control of Surgical 
Site Infections. Annals of Surgery 253(6), 1082-1093. 
 
AORN (1999) Standards, recommended practices and guidelines. AORN, Denver, p. 317. 
 
Bunn F., Cunningham M. & Handscomb K. (2006) Prophylactic antibiotics to prevent surgical site infection 
after breast cancer surgery. Cochrane Database of Systematic Review 2, p. CD005360. doi: 
10.1002/14651858.CD005360.pub2. 
 
Centers for Disease Control and Prevention (CDC). (2004) National Nosocomial Infection Surveillance 
(NNIS) system report, data summary from January 1992 through June 2004, issued October 2004.  
American Journal of Infection Control 32, 470-485. 
 
Chadwick D.R. & Shorthouse A.J. (1997) Wire-directed localization biopsy of the breast: an audit of results 
and analysis of factors influencing therapeutic value in the treatment of breast cancer. European Journal of 
Surgical Onchology 23, 128-33. 
 
Chen J., Gutkin Z. & Bawnik J. (1991) Postoperative infections in breast surgery. Journal of Hospital 
Infection 17, 61-65. 
 
Classe J.-M., Berchery D., Champion L., Pioud R., Dravet F. & Robard S. (2006) Randomized clinical trial 
comparing axillary padding with closed suction drainage for the axillary wound healing after 
lymphadenectomy for breast cancer. British Journal of Surgery 93, 820-824. 
 
Crowe M.J. & Cooke E.M. (1998) Review of case definitions for nosocomial infection. Towards consensus. 
Presentation by the Nosocomial Infection Surveillance Unit (NISU) to the Hospital Infection Liaison Group, 
subcommittee of the Federation of Infection Societies (FIS). Journal of Hospital Infection 39(1) 3-11. 
 
de Blacam C., Ogunleye A.A., Momoh A.O., Colakoglu S., Tobias A.M., Sharma R., Houlihan M.J. & Lee 
B.T. 2012. High Body Mass Index and Smoking Predict Morbidity in Breast Cancer Surgery. Annals of 
Surgery 255(3), 551-555.  
 
Emori T.G., Culver D.H., Horan T.C.,  Jarvis W.R., White J.W., Olson D.R., Banerjee S., Edwards J.R., 
Martone W.J.& Gaynes R.P. (1991) National Nosocomial Infections Surveillance System (NNIS): description 
of surveillance methods. American Journal of Infection Control 19, 19-35. 
 
Friedman N.D., Bull A.L., Russo P.L., Gurrun L. & Richards M. (2007) Performance of the National 
Nosocomial Infections Surveillance Risk Index in Predicting Surgical Site Infections in Australia. Infection 
Control and Hospital Epidemiology 28, 55-59. 
 
Gastmeier P., Bräuer H., Hauer T., Schuchmacher M., Daschner F. & Rűden H. (1999) How Many 
Nosocomial Infections Are Missed if Identification is Restricted to Patients With Either Microbiology Reports 
or Antibiotic Administration. Infection Control and Hospital Epidemiology; 20(2), 124-127.    
 
Risk factors for SSI in breast surgery 
 
16
Gaynes R.P., Culver D.H., Horan T.C., Edwards J.R., Richards C. & Tolson J.S. (2001) Surgical Site 
infection (SSI) rates in the United States, 1992-1998: the national Nosocomial Infections Surveillance 
System basic SSI risk index. Clinical Infectious Diseases 33(S), 69-77. 
 
Geubbels  E.L.P.E., Grobbe D.E., Vandenbroucke-Grauls C.M.J.E., Wille J.C. & de Boer A.S. (2006) 
Improved Risk Adjustment for Comparison of Surgical Site Infection Rates. Infection Control and Hospital 
Epidemiology 27, 1330-39. 
 
Gomm R. (2004) Using Bureaucratic Data in Research. In Social Research Methodology. A critical 
introduction. (Gomm R.) Palgrave Macmillan, Hampshire, UK, pp. 139-149. 
 
Jarvis W.R., Gaynes R.P., Horan T.C., Alonso-Echanove J., Emori T.G., Fridkin S.K., Lawton R.M., Richards 
M.J., Wright G.C., Culver D.H., Abshire J.P., Edwards J.R., Henderson T.S., Peavy G.E., Tolson J.S. & 
Wages J.T. (1998) National Nosocomial Infection Surveillance (NNIS) System Report, Data Summary from 
October 1986- April 1998, Issued June 1998. American Journal of Infection Control 26(5), 522-533. 
 
Jain P.K., Sowdi R., Anderson A.D.G & MacFie J. (2004) Randomized clinical trial investigating the use of 
drains and fibrin sealant following surgery for breast cancer. British  Journal of Surgery 91(1), 54–60. 
 
Kjønniksen I., Andersen B.M., Søndenaa V.G. & Segadal L. (2002) Pre-operative Hair Removal ˗ a 
Systematic Literature Review. AORN Journal 75(5), 928-40. 
 
McKibben L., Horan T.C., Tokars J.I., Fowler G., Cardo D.M., Pearson M.L.& Brennan P.J. (2005) Guidance 
on Public Reporting of Healthcare-Associated Infections: Recommendations of the Healthcare Infection 
Control Practices Advisory Committee. Infection Control and Hospital Epidemiology 26, 580-587. 
 
Miner A.L., Sands K.E., Yokoe D.S., Freedman J., Thompson K., Livingston J.M. & Platt R. (2004) Enhanced 
Identification of Postoperative Infections among Outpatients. Emerging Infectious Diseases 10(11), 1931-7. 
 
Monge Jodrá V., Díaz-Agero Perez C., Sainz de los Terreros Soler L., Saa Requejo C., Dacosta Ballesteros 
D., & the Quality Control Indicator Working Group. (2006) Results of Spanish national nosocomial infection 
surveillance network (VICONOS) for surgery patients from January 1997 through December 2003. American 
Journal of Infection Control 34(3), 134-141. 
 
Moro M.L., Morsillo F., Tangenti M., Mongardi M., Pirazzini M.C., Ragni P., & the ICN Regional Group. 
(2005) Rates of surgical-site infection: an international comparison. Infection Control and Hospital 
Epidemiology 26, 442-448. 
 
Munro B.H. (1997) Logistic Regression. In Statistical Methods for Health Care Research. (B.H. Munro ed.)  
3rd Ed. Lippincott, Philadelphia, pp. 287-309. 
 
National Nosocomial Infection Surveillance (NNIS) (2002) System Report, Data Summary from January 1992 
to June 2002, issued August 2002. Americal Journal of Infection Control 30, 458-475. 
 
Oertli D., Laffer U., Haberthuer F., Kreuter U. & Harder F. (1994) Perioperative and postoperative tranexamic 
acid reduces the local wound complication rate after surgery for breast cancer. British Journal of Surgery 
1994; 81(6), 856-859. 
 
Olsen M.A., Chu-Ongsakul S., Brandt K.E., Dietz J.R., Mayfield J. & Frazer V.J. (2008) Hospital-Associated 
Costs Due to Surgical Site Infection After Breast Surgery. Archieves of Surgery 143(1), 53-50.   
 
Platt R., Zaleznik D.F., Hopkins C.C., Dellinger E.P., Karchmer A.W., Bryan C.S., Burke J.F., Wikler M.A., 
Marino S.K., Holbrook K.F., Tosteson T.D. & Segal M.R. (1990) Perioperative antibiotic prophylaxis for 
herniorraphy and breast surgery. New England Journal of Medicine 322(3), 153-160. 
 
Prospero E., Cavicci A., Bacelli S., Barbadoro P., Tantucci L.& DÉrrico M.M. (2006) Surveillance for Surgical 
Site Infection After Hospital Discharge: A Surgical Procedure-Specific Perspective. Infect Control Hosp 
Epidemiol 27, 1313-17. 
 
Risk factors for SSI in breast surgery 
 
17
Reilly J., Allardice G., Bruce J., Hill R. & McCoubrey J. (2006) Procedure-Specific Surgical Site Infection 
Rates and Post Discharge Surveillance in Scotland. Infection Control and Hospital Epidemiology 27(12), 
1318-1323.   
 
Rioux C., Grandbastien B. & Astagneau P. (2007) Impact of a six-year control programme on surgical site 
infections in France: results of the INCISO surveillance. Journal of Hospital Infection 66(3), 217-223. 
 
Tanner J., Woodings D. & Moncaster K. (2006) Pre-operative hair removal to reduce surgical site infection. 
Cochrane Database of Systematic Reviews 3, p. CD004122. doi: 10.1002/14651858.CD004122.pub3. 
 
Throckmorton A.D., Boughey J.C., Boostrom S.Y., Holifield A.C., Stobbs M.M., Hoskin T., Baddour L.M. & 
Degnim A.C. (2009) Postoperative Prophylactic Antibiotics and Surgical Site Infection Rates in Breast 
Surgery Patients. Annals of Surgical Onchology 16, 2464-69. 
 
Vilar-Compte D., Roldan-Marín R., Robles-Vidal C. & Volkow P. (2006) Surgical Site Infection (SSI) Rates 
Among Patients Who Underwent Mastectomy After the Introduction of SSI Prevention Policies. Infect Control 
Hosp Epidemiol 27(8), 829-34. 
 
Vilar-Compte D., Rosales S., Hernandez-Mello N., Maafs E. & Volkow P. (2009) Surveillance, control, and 
prevention of surgical site infections in breast cancer surgery: A 5-year experience. American Journal of 
Infection Control 37, 674-9. 
 
Wagman L.D., Tegtmeier B., Beatty J.D., Kloth D.D., Kokal W.A., Riihimäki D.U. & Terz J.J. 1990A 
prospective, randomized double-blind study of the use of antibiotics at the time of mastectomy. Surgery 
Gynecology Obstetrics; 170(1), 12–16. 
 
Wilson A.P.R., Gibbons C., Reeves B.C., Hodgsin B., Liu M., Plummer D., Krikowski Z.H. Bruce J., Wilson J. 
& Pearson A. (2004) Information in practice. Surgical wound infection as a performance indicator: agreement 
of common definitions of wound infection in 4773 patient. British Medical Journal 329: 720-723. 
 
Witt A., Yavuz D., Walchetseder C., Strohmer H. & Kubista E. (2003) Pre-operative Core Needle Biopsy as 
an Independent Risk Factor for Wound Infection After Breast Surgery. Obstetrics & Gynecology 101(4), 745-
750. 
 
Yokoe D.S., Shapiro M., Simchen E., & Platt R. (1998) Use of antibiotic exposure to detect postoperative 
infections. Infection Control and Hospital Epidemiology 19, 317-322. 
 
 
 
 
 
 
 
 
Risk factors for SSI in breast surgery 
 
18
 
Table 1 Demographic and clinical characteristics of breast surgery patients.  
 SSI rate 
YES 
   n    (%) 
NO 
    n       (%) 
Univariate 
OR 
P CI 95% 
Patient-related factors  
Age (years) 
     ≤65 
     >65   
Total 
 
 
49   (6.2) 
18   (9.4) 
67   (6.8) 
 
 
739  (93.8) 
173  (90.6) 
912  (93.2) 
 
 
 
1.57 
 
 
 
.118 
 
 
 
0.89–2.76 
American Society of Anesthesiologists (ASA) score   
     1 or 2  
     3–5  
Total 
 
47   (5.7) 
20 (12.9) 
67   (6.9) 
 
774  (94.3) 
135  (87.1) 
909  (93.1) 
 
 
2.44 
 
 
.002 
 
 
1.40–4.24 
Wound class  
     1 or 2  
     3 or 4  
Total 
 
62   (6.4) 
   4 (36.4) 
66   (6.7) 
 
905  (93.6) 
7  (63.6) 
912  (93.3) 
 
8.34 
 
.001 
 
2.38–29.26 
Diabetes mellitus  
     No 
     Yes  
Total 
 
64   (6.8) 
3   (7.9) 
67   (6.8) 
 
878  (93.2) 
35  (92.1) 
913  (93.2) 
 
 
1.18 
 
 
.792 
 
 
0.352–3.928 
Body mass index (kg/m2 )  
     <25 
     ≥25 
Total 
 
20   (4.6) 
40   (9.3) 
60   (6.9) 
 
418  (95.4) 
392  (90.7) 
810  (93.1) 
 
 
2.13 
 
 
.007 
 
 
1.22–3.71 
Re-operated patient  
     No 
     Yes  
Total 
 
37   (5.2) 
30   (11 ) 
67   (6.8) 
 
673  (94.8) 
242  (89.0) 
915  (93.2) 
 
 
2.25 
 
 
.002 
 
 
1.36–3.73 
Procedure-related factors  
Preoperative hospital stay (h) 
     <48  
     ≥48  
Total 
 
 
67   (6.9) 
0   (0.0) 
67   (6.8) 
 
 
907  (93.1) 
5  (  0.5) 
912  (93.2) 
 
 
- 
 
 
- 
 
 
- 
Timing of preoperative antimicrobial prophylaxis (AMP) 
     30–60 min before incision 
     No AMP or inadequate timing of AMP  
Total 
 
4 (17.4)
63 (6.6) 
67 (6.8) 
 
19 (82.6) 
895 (93.4) 
914 (93.2) 
 
 
.334 
 
 
.053 
 
 
0.110–0.013 
Preoperative surgical removal of hair 
     No 
     Yes 
Total 
 
42   (7.3) 
25   (6.2) 
67   (6.8)   
 
536  (92.7) 
377  (93.8) 
913  (93.2) 
 
 
0.85 
 
 
.523 
 
 
0.51–1.41 
Preoperative skin condition  
     Intact  
     Non-intact 
Total 
 
18   (9.0) 
49   (6.3) 
67   (6.9) 
 
181  (91.0) 
730  (93.7) 
911  (93.1) 
 
 
1.48 
 
 
.172 
 
 
0.84–2.65 
Invasive preoperative tumour marking  
     No 
     Yes 
Total 
 
45   (6.9) 
22   (6.7) 
67   (6.8) 
 
605  (93.1) 
307  (93.3) 
912  (93.2) 
 
 
0.96 
 
 
.890 
 
 
0.57–1.63 
Axillary evacuation 
     No 
     Yes  
Total 
 
22  (5.2)
45     (8) 
67  (6.8) 
 
397 (94.8)
517 (92)
914 (93.2) 
 
 
1.57 
 
 
.093 
 
 
0.93–2.66 
Surgical drain 
      No 
     Yes 
Total 
 
10     (3) 
57  (8.8) 
67 ( 6.8) 
 
325    (97) 
590 (91.2) 
915 (93.2) 
 
 
3.14 
 
 
 
.001 
 
 
1.58–6.23 
Duration of surgery (min) 
     <87 
     ≥87 
Total 
 
45 (6.2) 
22    (9) 
67 (6.9) 
 
680 (93.8) 
222    (91) 
902 (93.1) 
 
 
1.50 
 
 
.137 
 
 
0.88–2.55 
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Table 2 Surgical-site infections among all breast-operated, lumpectomy, and mastectomy 
patients by patient- and procedure-related factors. 
 
 All breast-operated patients 
(N=982) 
Lumpectomy patients 
(n=700) 
Mastectomy patients  
(n=282) 
 SSI rate (%) 66 (6.7) 33 (4.7) 25 (8.9) 
 OR P CI 95% OR P CI 95% OR P CI 95% 
Patient-related factors          
ASA score 3–5  2.1 .018 1.13–3.90 2.0 .110 0.54–4.72 1.9 .147 0.79–4.95 
Contaminated or dirty 
wound 
6.8 .014 1.47–31.27 4.2 .217 0.43–1.74 11.9 .051 0.99–44.93 
BMI ≥25 kg/m2  1.8 .038 1.03–3.33 2.6 .028 1.11–6.03 1.4 .454 0.59–3.29 
Re-operated patient  2.6 .001 1.53–4.61 2.4 .017 1.17–5.04 2.7 .027 1.12–6.39 
Procedure-related 
factors 
         
Surgical drain 3.3 .003 1.52–7.11 3.2 .008 1.35–7.62 1.3 .857 0.14–10.34 
          
Multivariate  
model summary 
-2LL=388.670 -2LL=230.135 -2LL=155.563 
Missing cases 118 88 30 
 
ASA: American Society of Anesthesiologists 
BMI: Body Mass Index 
 
  
 
